We are excited to have Julia Brosch visiting us from LMU (Ludwig Maximilian University of Munich). Julia obtained her BSc (physics) in 2014 (thesis: multi-phase tracer kinetics in Lutetium-177-DOTATATE therapy of NETs for optimized kidney dosimetry) and MSc (medical physics) in 2017 (thesis: dosimetric approaches for Yttrium-90 SIRT based on quantitative SPECT and PET images). Julia started her PhD in November 2017, and is part of the research training group GRK2274. Her overall research involves Monte Carlo based dosimetry for radionuclide therapy with focus on Lutetium-177-PSMA therapy. During her stay with us, she aims to learn how to use GATE for simulation of 3D dose distributions for Lu-177-PSMA, and to investigate differences in doses to organs at risk using different dosimetric approaches. We are already very impressed by Julia’s enthusiasm and depth of knowledge.
Visiting PhD Candidate from University of Munich
Categories
Share This
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.